|
National Stock Number(NSN): 6505-01-301-2670 (6505013012670, 013012670)
| NIIN: |
01-301-2670 |
Item Name: |
Item Name not available. |
INC: |
00000
|
| FSC: |
6505
|
Assignment Date: |
May-26-1989 |
CRIT: |
|
IIG: |
00000 |
| ISC: |
2 |
Date Standardized: |
Dec-11-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Nov-01-1995 |
PMIC: |
A |
FIIG: |
|
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
|
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
7628-89 |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
3 |
1 |
|
|
|
|
|
|
|
|
|
9-0676 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
CEFADYL |
0MN35
|
BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
CEFADYL |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00015-7628-18 |
0MN35
|
BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00015-7628-18 |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
|
|
|
|
|
|
A |
$0.00 |
|
|
------- |
Dec-01-1995 |
H |
| DF |
S9M |
Y |
|
Q |
U |
1 |
F |
$21.04 |
PG |
|
------- |
Nov-01-1995 |
H |
| DM |
S9M |
Y |
Z |
Q |
U |
1 |
M |
$21.04 |
PG |
|
13M2--1 |
Jun-01-1994 |
H |
| DN |
S9M |
V |
|
Q |
U |
1 |
N |
$21.04 |
PG |
|
9L----- |
Nov-01-1995 |
H |
| DS |
S9M |
Y |
|
Q |
U |
1 |
D |
$21.04 |
PG |
|
------- |
Nov-01-1995 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1.000 GRAMS CEPHAPIRIN EQUIVALENT |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL, SINGLE DOSE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1.000 GRAMS OF ACTIVE INGREDIENT |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
39.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
1.50 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
60 |
| FEAT |
SPECIAL FEATURES |
15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW; ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715 |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUCB |
UNIT OF ISSUE CUBE |
0.02 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.65 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
| FSKX |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
| MC15 |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
| N9LM |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
|